We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Innovision Res. | LSE:INN | London | Ordinary Share | GB0030308448 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 34.75 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMINN
RNS Number : 8864Y
Innovision Research&Technology PLC
10 September 2009
Innovision Research & Technology plc
(the "Company")
Directors' shareholdings
The Company was today notified that Brian McKenzie and Dr Ian Buckley-Golder,
Directors of the Company, have today transferred their new ordinary shares of 1p
each in the Company ("Ordinary Shares") acquired as part of the placing of new
Ordinary Shares announced on 3 July 2009 to their respective SIPPs.
Brian McKenzie sold 41,600 Ordinary Shares at 21.5pence per share and
re-acquired 41,600 Ordinary Shares through his SIPP at 22.49pence per share. The
sale and acquisition were both made on 10 September 2009 and Brian McKenzie's
holding in the Company remains 41,600 Ordinary Shares which equates to
approximately 0.04% of the Company's issued share capital.
Dr Ian Buckley-Golder sold 41,600 Ordinary Shares at 21.5pence per share and
re-acquired 41,600 Ordinary Shares through his SIPP at 22.49pence per share. The
sale and acquisition were both made on 10 September 2009 and Dr Ian
Buckley-Golder's holding in the Company remains 72,350 Ordinary Shares which
equates to approximately 0.08% of the Company's issued share capital.
Enquiries:
+--------------------------------------------+------------------------------+
| Innovision Research & Technology plc | Tel: 01285 888 200 |
+--------------------------------------------+------------------------------+
| David Wollen, Chief Executive Officer | |
+--------------------------------------------+------------------------------+
| Brian McKenzie, Finance Director | |
+--------------------------------------------+------------------------------+
| | |
+--------------------------------------------+------------------------------+
| KBC Peel Hunt Ltd (Nominated Adviser & | Tel: 020 7418 8900 |
| Broker) | |
+--------------------------------------------+------------------------------+
| Jonathan Marren | |
+--------------------------------------------+------------------------------+
| David Anderson | |
+--------------------------------------------+------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSSFEFMSSUSESU
1 Year Innovision Research&technology Chart |
1 Month Innovision Research&technology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
